POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.
POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.
复制标题
DOI:
10.1101/gad.314815.118
复制
发表时间:
2018-07-01
影响因子:
10.5
通讯作者:
Vakoc CR
中科院分区:
文献类型:
--
作者:
Huang YH;Klingbeil O;He XY;Wu XS;Arun G;Lu B;Somerville TDD;Milazzo JP;Wilkinson JE;Demerdash OE;Spector DL;Egeblad M;Shi J;Vakoc CR
Here, Huang et al. applied domain-focused CRISPR screening to small cell lung cancer to identify a novel molecular subtype defined by the expression of and dependency on transcription factor POU2F3. They also demonstrate that POU2F3 is expressed exclusively in variant SCLC tumors that lack expression of neuroendocrine markers, which instead express markers of a chemosensory lineage known as tuft cells. Small cell lung cancer (SCLC) is widely considered to be a tumor of pulmonary neuroendocrine cells; however, a variant form of this disease has been described that lacks neuroendocrine features. Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) POU2F3 (POU class 2 homeobox 3; also known as SKN-1a/OCT-11) as a powerful dependency in a subset of SCLC lines. An analysis of human SCLC specimens revealed that POU2F3 is expressed exclusively in variant SCLC tumors that lack expression of neuroendocrine markers and instead express markers of a chemosensory lineage known as tuft cells. Using chromatin- and RNA-profiling experiments, we provide evidence that POU2F3 is a master regulator of tuft cell identity in a variant form of SCLC. Moreover, we show that most SCLC tumors can be classified into one of three lineages based on the expression of POU2F3, ASCL1, or NEUROD1. Our CRISPR screens exposed other unique dependencies in POU2F3-expressing SCLC lines, including the lineage TFs SOX9 and ASCL2 and the receptor tyrosine kinase IGF1R (insulin-like growth factor 1 receptor). These data reveal POU2F3 as a cell identity determinant and a dependency in a tuft cell-like variant of SCLC, which may reflect a previously unrecognized cell of origin or a trans-differentiation event in this disease.
登录
查看更多内容
影响因子:
8.8
作者:
Borromeo MD;Savage TK;Kollipara RK;He M;Augustyn A;Osborne JK;Girard L;Minna JD;Gazdar AF;Cobb MH;Johnson JE
通讯作者:
Johnson JE
影响因子:
18.4
作者:
Bhagwat AS;Vakoc CR
通讯作者:
Vakoc CR
影响因子:
64.8
作者:
Gerbe F;Sidot E;Smyth DJ;Ohmoto M;Matsumoto I;Dardalhon V;Cesses P;Garnier L;Pouzolles M;Brulin B;Bruschi M;Harcus Y;Zimmermann VS;Taylor N;Maizels RM;Jay P
通讯作者:
Jay P
影响因子:
2.5
作者:
Bezencon, C.;Fuerholz, A.;Damak, S.
通讯作者:
Damak, S.
DOI:
10.1126/science.aaf1648
发表时间:
2016-03-18
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Howitt MR;Lavoie S;Michaud M;Blum AM;Tran SV;Weinstock JV;Gallini CA;Redding K;Margolskee RF;Osborne LC;Artis D;Garrett WS
通讯作者:
Garrett WS